Where Global Innovation
and Capital Meet

Goldfinch Bio sparks $100m series B

Jul 1, 2020 • Callum Cyrus

Advancing research from institutions including Harvard, kidney disease-focused Goldfinch Bio now has its sights on clinical trials.

Goldfinch Bio, a US-based kidney disease medication developer co-founded by faculty from multiple research institutions, yesterday closed an oversubscribed $100m series B round led by Eventide Asset Management.
Biopharmaceutical firm Gilead Sciences, Wellington Management Company, Ally Bridge Group, Casdin Capital, Irving Investors, Yonjin Capital and Schroeder Adveq took part in the round.
Funds and accounts managed by BlackRock also participated, as did undisclosed additional institutional investors.
Founded in 2016, Goldfinch Bio hopes to deliver kidney disease treatments…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

University of Notre Dame tries new, supersized approach to creating spinouts

A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.

How Basel supercharged its spinout rate

Basel has quietly built a life sciences ecosystem that’s becoming hard to ignore.

Crumbling system, fragile lives: can spinouts help in the senior care crisis?

From a chest-worn device to help with Parkinson's symptoms to stress measuring socks — here are the spinouts providing support for senior citizens.

Events

GCV Institute: Landing the Value of Corporate Venturing

May 6 -
May 9, 2024
Online

Find out more All events

Events

Webinar: CVCs and the art of the follow-on

May 8, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

May 21 -
May 22, 2024
Online

Find out more All events

Events

GCV Symposium 2024

Jun 24 -
Jun 26, 2024
London (UK)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.